Ambiguous Carcinogens and Their Regulation1
- 1 June 1985
- journal article
- review article
- Published by Wiley in Risk Analysis
- Vol. 5 (2) , 151-156
- https://doi.org/10.1111/j.1539-6924.1985.tb00162.x
Abstract
Examination of five animal and one human studies suggest that certain agents increase the incidence of some cancers but simultaneously reduce the incidence of other cancers. Yellow die #3, for example, sharply increases the incidence of liver tumors but practically eliminates naturally occurring leukemia/lymphoma in F-344 male rates. Such ambiguity in the action of presumed carcinogens suggests that caution must be used by regulatory bodies in proscribing suspected carcinogens, or even in recommending changes in lifestyle or dietary habits as a means of reducing incidence of cancer.Keywords
This publication has 6 references indexed in Scilit:
- Carcinogenesis: Testing for carcinogenicity and the problem of pseudocarcinogenicityNature, 1983
- Patterns of tumor incidence in two-year cancer bioassay feeding studies in fischer 344 ratsFundamental and Applied Toxicology, 1983
- Influence of γ Irradiation on the Development of Neoplastic Disease in Mice: I. Reticular Tissue TumorsRadiation Research, 1979
- Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in ratsToxicology and Applied Pharmacology, 1978
- Associations Between Tumor Types in a Large-Scale Carcinogenesis Study of CF-1 Mice2JNCI Journal of the National Cancer Institute, 1974
- Liver tumours in CF-1 mice exposed for limited periods to technical DDTZeitschrift für Krebsforschung und Klinische Onkologie, 1974